Oncotelic Therapeutics Inc. has issued 1,422,613 warrants to purchase shares of its common stock at an exercise price of $0.15 per share in connection with a Securities Purchase Agreement with Mast Hill Fund, LP. The warrants are part of a financing arrangement involving a convertible promissory note with a principal amount of $398,333.33. The shares of common stock issuable upon exercise of the warrants have not been registered under the Securities Act of 1933 and may only be offered or sold pursuant to an exemption from registration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncotelic Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-004237), on January 29, 2026, and is solely responsible for the information contained therein.